This prospective, multi-center, open-label trial, CAN-BIND-1 was conducted between 2012 and 2017.
Your search for major depressive disorder returned 3 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Previous studies have found that perinatal women have had detriments to sleep and depression during the pandemic; however, all studies to date in the perinatal setting have lacked a comparator group, so robust conclusions about the effect of the COVID-19 pandemic have not been elucidated.
Solriamfetol, a dopamine-norepinephrine reuptake inhibitor, improves excessive daytime sleepiness in OSA regardless of primary OSA therapy adherence.